[3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
about
Imaging the serotonin transporter during major depressive disorder and antidepressant treatmentLocal potentiation of excitatory synapses by serotonin and its alteration in rodent models of depressionCentral serotonin system in Dystonia musculorum mutant mice: biochemical, autoradiographic and immunocytochemical data.Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.P-chlorophenylalanine increases glutamate receptor 1 transcription in rat amygdala.Role of monoamine systems in activation of zif268 by cocaineArchitectonic distribution of the serotonin transporter within the orbitofrontal cortex of the vervet monkeyFurther Electrochemical and Behavioural Evidence of a Direct Relationship Between Central 5-HT and Cytoskeleton in the Control of Mood.Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.Regulation of central serotonin transporters by chronic lithium: an autoradiographic study.
P2860
Q24683135-A9332241-9BCA-481D-8A46-7812B9EACB26Q30538101-8CC2F24A-7FE6-4295-A493-2E4A08A94355Q30600996-3DE82C39-F598-4D21-A2B1-B541625600EBQ31033312-D4B2AF2D-5224-4410-9081-77FFD45FD32DQ35216254-ECE6C8F6-B7CE-4846-ABE8-E1738F0A144AQ35266322-744EDB1C-E42D-4673-B0FF-52BC49B36E8CQ36131232-A4969CE7-E847-48EF-AD59-1DA52B5973FFQ42223560-BD6CCE5D-9544-4A62-8366-AB710E77B223Q48402641-4B395B1F-5FA1-47A4-9142-CD6201CA9F2BQ48574615-5CC016B3-5B37-4A6C-B089-A0D0D5813309Q48632816-4399D84D-5E02-45E7-AD6A-73873A627D2A
P2860
[3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@en
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@nl
type
label
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@en
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@nl
prefLabel
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@en
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@nl
P2093
P2860
P1476
[3H]paroxetine binding and ser ...... p-chloroamphetamine treatment.
@en
P2093
P2860
P304
P356
10.1111/J.1471-4159.1992.TB09303.X
P407
P50
P577
1992-01-01T00:00:00Z